EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Understanding and reversing mammary tumor-driven reprogramming of myelopoiesis to reduce metastatic spread

Hannah Garner, Moreno Martinovic, Ning Qing Liu, Noor A M Bakker, Irene Querol Velilla, Cheei-Sing Hau, Kim Vrijland, Daphne Kaldenbach, Marleen Kok, Elzo de Wit, Karin E de Visser

Cancer Cell · 2025-07 · 43 (7) · 1279-1295.e9

DOI: 10.1016/j.ccell.2025.04.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2025-07. Verfasst von Hannah Garner und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands. Elect…. Hauptthemen laut MEDLINE: Myelopoiesis, Neutrophils, Cellular Reprogramming, Breast Neoplasms. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Dutch Cancer Society, European Research Council, Nederlandse Organisatie voor Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor-induced systemic accumulation and polarization of neutrophils to an immunosuppressive phenotype is a potent driver of metastasis formation. Yet, how mammary tumors reprogram granulopoiesis at the molecular level and when tumor imprinting occurs during neutrophil development remains underexplored. Here, we combined single-cell, chromatin and functional analyses to unravel the tumor-driven reprogramming of granulopoiesis in the bone marrow, along with intervention studies aimed at reversing this process. We observe that mammary tumors accelerate commitment to the neutrophil lineage at the expense of lymphopoiesis and erythropoiesis without stimulating the development of a novel myeloid lineage. Moreover, tumor-directed immunosuppressive imprinting of neutrophils starts early in hematopoiesis. Treatment with anti-IL-1β normalizes tumor-induced granulopoiesis, reducing neutrophil immunosuppressive phenotype and mitigating metastatic spread. Together, these data provide molecular insights into the aberrant, tumor-driven neutrophil differentiation pathway leading to metastasis-promoting chronic inflammation and how it can be reversed to reduce metastatic spread.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyelopoiesisNeutrophilsCellular ReprogrammingBreast NeoplasmsMammary Neoplasms, ExperimentalAnimalsFemaleMiceNeoplasm MetastasisCell DifferentiationHumansInterleukin-1betaMice, Inbred C57BL

Stichwörter der Autor:innen

IL-1βbreast cancercancer-induced hematopoiesisimmunosuppressioninflammationmetastasismyelopoiesisneutrophil programmingneutrophils

Substanzen

Interleukin-1beta

Autor:innen und Institutionen

  • Department of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands. Electronic address: hannah.garner@mcgill.ca.
  • Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Department of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands; Department of Immunology, Leiden University Medical Centre, Leiden, the Net…
  • Department of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands.
  • Department of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Förderung

  • Dutch Cancer Society
  • European Research Council
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • Oncode Institute
  • Ministerie van Volksgezondheid, Welzijn en Sport

Zitieren

APA

Garner, H., Martinovic, M., Liu, N. Q., Bakker, N. A. M., Velilla, I. Q., Hau, C. S., Vrijland, K., Kaldenbach, D., Kok, M., de Wit, E., & de Visser, K. E. (2025). Understanding and reversing mammary tumor-driven reprogramming of myelopoiesis to reduce metastatic spread. Cancer Cell, 43(7), 1279-1295.e9. https://doi.org/10.1016/j.ccell.2025.04.007

Vancouver

Garner H, Martinovic M, Liu NQ, Bakker NAM, Velilla IQ, Hau CS, et al. Understanding and reversing mammary tumor-driven reprogramming of myelopoiesis to reduce metastatic spread. Cancer Cell. 2025;43(7):1279-1295.e9. doi:10.1016/j.ccell.2025.04.007

BibTeX
@article{Garner2025,
  author = {Garner, Hannah and Martinovic, Moreno and Liu, Ning Qing and Bakker, Noor A M and Velilla, Irene Querol and Hau, Cheei-Sing and Vrijland, Kim and Kaldenbach, Daphne and Kok, Marleen and de Wit, Elzo and de Visser, Karin E},
  title = {Understanding and reversing mammary tumor-driven reprogramming of myelopoiesis to reduce metastatic spread},
  journal = {Cancer Cell},
  year = {2025},
  volume = {43},
  number = {7},
  pages = {1279--1295.e9},
  doi = {10.1016/j.ccell.2025.04.007}
}
Kostenlos starten →